Alnylam Pharmaceuticals
ALNY
#880
Rank
$21.44 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ USA
Country
$182.41
Share price
0.33%
Change (1 day)
-0.33%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: $21.44 Billion

As of July 2021 Alnylam Pharmaceuticals has a market cap of $21.44 Billion. This makes Alnylam Pharmaceuticals the world's 880th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2021

Year Market cap Change
2021$21.50 B42.44%
2020$15.10 B16.87%
2019$12.92 B75.15%
2018$7.37 B-41.45%
2017$12.59 B292.16%
2016$3.21 B-59.89%
2015$8.01 B6.97%
2014$7.48 B82.71%
2013$4.09 B327.85%
2012$0.95 B175.09%
2011$0.34 B-16.59%
2010$0.41 B-43.36%
2009$0.73 B-28.02%
2008$1.02 B-13.62%
2007$1.18 B49.54%
2006$0.79 B207.77%
2005$0.25 B78.85%
2004$0.14 B